Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Fox

Showing results (141-150 of 154) with videos related to

Pageof 16
Sort By:
The Journal of Infectious Diseases|June 1, 1996
Dynamics of virus versus host interaction in children with human immunodeficiency virus type 1 infectionS Sei, H Akiyoshi, J Bernard, et al.
Human Pathology|May 1, 1992
Lymphoid pneumonitis in 50 adult patients infected with the human immunodeficiency virus: lymphocytic interstitial pneumonitis versus nonspecific interstitial pneumonitisW D Travis, C H Fox, K O Devaney, et al.
Journal of Dental Research|October 18, 2025
The AADOCR Position Statement on Topical FluorideP R Arany, M Charles-Ayinde, M Fontana, et al.
Nature Medicine|March 21, 1998
Evolutionary pattern of human immunodeficiency virus (HIV) replication and distribution in lymph nodes following primary infection: implications for antiviral therapyG Pantaleo, O J Cohen, T Schacker, et al.
The Journal of Infectious Diseases|June 3, 2000
Evaluation of lymph node virus burden in human immunodeficiency virus-infected patients receiving efavirenz-based protease inhibitor--sparing highly active antiretroviral therapyM Dybul, T W Chun, D J Ward, et al.
The Journal of Clinical Investigation|March 23, 2000
Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNAG P Rizzardi, R J De Boer, S Hoover, et al.
AIDS (London, England)|December 22, 1999
Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapyJ M Prins, S Jurriaans, R M van Praag, et al.
The Journal of Infectious Diseases|April 1, 1996
Antiretroviral monotherapy in early stage human immunodeficiency virus disease has no detectable effect on virus load in peripheral blood and lymph nodesO J Cohen, G Pantaleo, M Holodniy, et al.
Journal of Clinical Immunology|June 14, 2001
OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T cell depletionR M van Praag, J M Prins, M T Roos, et al.
Advances in Dental Research|November 21, 2019
Gender Inequalities in the Dental Workforce: Global PerspectivesT Tiwari, C L Randall, L Cohen, et al.
Pageof 16

Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
The Journal of Infectious Diseases|June 1, 1996
Dynamics of virus versus host interaction in children with human immunodeficiency virus type 1 infectionS Sei, H Akiyoshi, J Bernard, et al.
Human Pathology|May 1, 1992
Lymphoid pneumonitis in 50 adult patients infected with the human immunodeficiency virus: lymphocytic interstitial pneumonitis versus nonspecific interstitial pneumonitisW D Travis, C H Fox, K O Devaney, et al.
Journal of Dental Research|October 18, 2025
The AADOCR Position Statement on Topical FluorideP R Arany, M Charles-Ayinde, M Fontana, et al.
Nature Medicine|March 21, 1998
Evolutionary pattern of human immunodeficiency virus (HIV) replication and distribution in lymph nodes following primary infection: implications for antiviral therapyG Pantaleo, O J Cohen, T Schacker, et al.
The Journal of Infectious Diseases|June 3, 2000
Evaluation of lymph node virus burden in human immunodeficiency virus-infected patients receiving efavirenz-based protease inhibitor--sparing highly active antiretroviral therapyM Dybul, T W Chun, D J Ward, et al.
The Journal of Clinical Investigation|March 23, 2000
Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNAG P Rizzardi, R J De Boer, S Hoover, et al.
AIDS (London, England)|December 22, 1999
Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapyJ M Prins, S Jurriaans, R M van Praag, et al.
The Journal of Infectious Diseases|April 1, 1996
Antiretroviral monotherapy in early stage human immunodeficiency virus disease has no detectable effect on virus load in peripheral blood and lymph nodesO J Cohen, G Pantaleo, M Holodniy, et al.
Journal of Clinical Immunology|June 14, 2001
OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T cell depletionR M van Praag, J M Prins, M T Roos, et al.
Advances in Dental Research|November 21, 2019
Gender Inequalities in the Dental Workforce: Global PerspectivesT Tiwari, C L Randall, L Cohen, et al.
Pageof 16